Contract facts
FederalNo full NAICS 541712 intel page yet. Browse NAICS intelligence
FUNDING ONLY ACTION FOR SCOL, REALIGNMENTS & NEW FUNDING FOR OPTION PERIOD 2 is a federal award for W6qk Acc-Apg held by Aranea Solutions, Inc. Estimated value $142.8M ($36.3M obligated). Current period of performance ends Aug 5, 2024. Last award drew 3 bidders. Place of performance: RESTON, VA.
FUNDING ONLY ACTION FOR SCOL, REALIGNMENTS & NEW FUNDING FOR OPTION PERIOD 2
Recompete timing
PublicCurrent PoP ended Aug 5, 2024 (745 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract W56KGY19F0074?
W56KGY19F0074 (Funding ONLY ACTION for SCOL realignments) is a W6qk Acc-Apg award with an estimated value of $142.8M, currently held by Aranea Solutions, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is W56KGY-19-F-0074?
W56KGY-19-F-0074 is the dashed form of PIID W56KGY19F0074 (Funding ONLY ACTION for SCOL realignments), held by Aranea Solutions, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded W56KGY19F0074?
W6qk Acc-Apg awarded W56KGY19F0074 to Aranea Solutions, Inc.
Who is the incumbent on W56KGY19F0074?
Aranea Solutions, Inc is the incumbent. The current period of performance ends Aug 5, 2024.
When does Aranea Solutions, Inc’s W56KGY19F0074 come up for recompete?
SCOUT tracks a period-of-performance end of Aug 5, 2024. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.